Cough, Cold and Allergy (Hay Fever) Remedies in Israel

PROSPECTS

Significant growth due to an unexpected long and hard winter

The winter in Israel is usually short and warm and even shorter and warmer winters have been witnessed over the past several years; however, the 2018//2019 winter was longer and more severe, which led to a significant increase in coughs and colds among the population, supporting growth of cough, cold and allergy (hay fever) remedies. Nasal sprays in particular registered strong retail value growth, as did combination products - cough, cold and allergy (hay fever) remedies, as consumers sought to combat several ailments with one solution.

Growth in nasal sprays as salt water sprays largely used for children

Salt water sprays have become increasingly popular for use by children in recent years. These products are regarded as more natural and gentle on the nasal tissues of young people than standard OTC products.

Growth to slow as winters return to more normal patterns

Cough, cold and allergy (hay fever) remedies are seasonal products and are therefore much affected by the changes in weather and climate. Therefore, as winters will likely return to more normal patterns, growth levels of cough, cold and allergy (hay fever) remedies are expected to reflect this over the forecast period.

COMPETITIVE LANDSCAPE

Teva Pharmaceutical Industries extends its lead

Teva Pharmaceutical Industries extended its lead in cough, cold and allergy (hay fever) remedies in 2019 thanks to its Acamol range, which leads combination products, and Alrin, which is strong in nasal sprays. These brands are widely recognised, and are often consumers' go-to products for congestion and colds.

Dexcel Pharma continues to grow

Dexcel Pharma continued to grow and gain share in 2019 thanks to its popular Zyllergy and Dexamol brands. Dexamol Cold is the second leading brand in combination products - cough, cold and allergy (hay fever) remedies, and it continued to gain ground in 2019.

GSK Consumer Healthcare extends its lead in nasal sprays

GSK Consumer Healthcare’s Otrivin extended its lead in nasal sprays, a category which also achieved strong overall growth in 2019. The company is expected to continue to perform well during the forecast period as Otrivin is a well-known and popular treatment for colds.

Files are delivered directly into your account within a few minutes of purchase.